Page 7: Research news on Immune Evasion

Immune evasion is a biological process by which pathogens, tumor cells, or other aberrant cells avoid detection, recognition, or elimination by the host immune system, thereby promoting persistence and proliferation. Mechanisms include antigenic variation, downregulation or loss of major histocompatibility complex (MHC) molecules, expression of immune checkpoint ligands (e.g., PD-L1), secretion of immunosuppressive cytokines, induction of regulatory T cells or myeloid-derived suppressor cells, and shielding of antigens within biofilms or physical barriers. This process critically influences infection chronicity, tumor progression, vaccine efficacy, and the outcome of host–pathogen or host–tumor coevolution.

With AI, researchers find increasing immune evasion in H5N1

The H5N1 avian influenza virus has infected birds and mammals around the world. As of June 2025, 70 people have been infected, and one person has died in the United States. A new analysis suggests that the virus is evolving ...

Smart nanotherapy enhances immune attack on melanoma

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

page 7 from 10